Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Stenham acquires Montier Partners

Monday, September 06, 2010
Opalesque Industry Update - Stenham Asset Management, the multi-award winning asset management firm, has announced that it has substantially augmented its investment team with the acquisition of Montier Partners, a niche discretionary investment management provider. The deal was completed on 1 September 2010.

Dominique Montier, founder of Montier Partners, with 33 years’ investment experience, and Jeremy Alun-Jones, CIO of Montier Partners with 26 years’ investment experience, will join Stenham’s investment committee, which will now comprise nine investment professionals, with an average of 20 years’ investment experience. Jeremy will assume the role of Managing Director, which will allow Kevin Arenson, currently Managing Director and CIO, to focus exclusively on investment management and risk control. The rest of the Montier team joining Stenham include two senior research analysts and four business development/client service professionals.

Montier Partners was founded in 1996 to act as an investment advisor to its sister company Montier Guernsey LP which manages diversified hedge fund portfolios for family offices and institutions. Total assets are over US$ 400 million, bringing Stenham Asset Management’s total assets under management to US$ 3.5 billion.

Stenham Asset Management has been active in fund management for over 25 years focusing exclusively on delivering absolute returns for pension funds, charities, asset managers and family offices, including both discretionary portfolios and funds of hedge funds.

Kevin Arenson said: ‘We have, for some time now, been contemplating the separation of the roles of Managing Director and CIO at Stenham to allow me to concentrate exclusively on managing the Stenham portfolios together with the investment committee. The attraction of Montier was that it provided us with a highly suitable candidate for the position of Managing Director of Stenham Asset Management, expanded the current business development team and simultaneously augmented the investment team both at an operational and investment committee level.

We have known Montier Partners for a number of years and have been impressed with the ethos and owner-managed culture at Montier which, like that of Stenham, has capital preservation and a commitment to absolute returns with low volatility, at its heart. I look forward to working with Jeremy in his capacity as MD of our business and to the experience that he and Dominique will bring to our investment committee.’

Dominique Montier, Founder and CEO, Montier Partners Ltd added: ‘Stenham has its origins as a manager of family money like Montier and this means that at our core, we share the same values in terms of investment philosophy and risk control. I am looking forward to playing an active role in assessing future investments and looking after my clients’ assets for many years to come.’

Jeremy Alun-Jones commented: ‘We are delighted to be joining Stenham. They have an outstanding 25 year track record of achieving strong absolute returns but more importantly achieving these returns with a focus on managing and mitigating risks, both investment and operational. We were particularly attracted by the breadth of experience in their investment team and their substantial operational due diligence capabilities. I am looking forward to taking on the role of Managing Director which will allow Kevin to focus exclusively on managing the portfolios. Together we are confident we can continue to evolve and grow the Stenham business in the best interests of all our clients.’

(press release)


Stenham Asset Management has been active in fund management for over 20 years focusing exclusively on delivering absolute returns, and has built a multiple award-winning track record. It provides market-leading solutions for pension funds, charities, asset managers and family offices, including both discretionary portfolios and funds of hedge funds. Its clients are located mainly in the UK and Channel Islands, Europe, Southern Africa, Latin America and Japan. Total assets as at July 2010 were US$ 3.1 billion. Source


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its